Question explored with the scientific record
Pomegranate
The evidence for pomegranate is mixed: it can lower blood pressure and blood sugar in some people, but the effects depend heavily on your gut bacteria, and one study found it raised triglycerides.
The retrieved studies are a small sample of the literature, not a complete review. What they show is that pomegranate's benefits are not universal. A 2017 trial in 49 overweight adults found that pomegranate extract only improved cholesterol and blood lipids in people with a specific gut bacteria profile (urolithin metabotype B); the other two-thirds of participants saw no benefit [4]. A 2010 trial in 46 healthy students found pomegranate juice lowered systolic blood pressure only in those who already had pre-hypertension, not in the group overall [1]. A 2014 trial in 85 type 2 diabetics found that a single dose of fresh juice lowered fasting glucose and improved insulin function three hours later [6].
But the picture is not all positive. A 2017 crossover trial in 30 people with metabolic syndrome found that while pomegranate juice lowered blood pressure and a marker of inflammation (hs-CRP), it also raised triglycerides and VLDL cholesterol [2]. A 2021 trial in 44 people with fatty liver disease found pomegranate extract improved weight, blood sugar, and cholesterol, but the study was small and the placebo group gained weight, which may exaggerate the apparent benefit [3]. A 2024 study using a mixed fruit extract that included pomegranate found it increased an antioxidant enzyme (catalase) but did not change blood pressure, body measurements, or inflammatory markers [5].
The bottom line: pomegranate is not a magic bullet. It may help some people with blood pressure or blood sugar, but it can also worsen triglycerides. The effect depends on your individual gut bacteria, which you cannot know without testing. The studies are small, short-term, and none track hard outcomes like heart attacks or death.
My call: pomegranate may offer modest benefits for blood pressure and blood sugar in specific subgroups, but the evidence is thin and includes a signal of harm for triglycerides. Confidence: low.
Sources used 6
-
Pomegranates ( Punica granatum ) and their effect on blood pressure: a randomised double-blind placebo-controlled trial
This study investigates the effects of pomegranate juice supplementation on blood pressure in healthy students, revealing no significant impact on systolic blood pressure overall, but a notable reduction in those with pre-hypertension.
DOI: 10.1017/S0029665109992837 -
Effects of Pomegranate Juice on Cardiovascular Risk Factors in Patients with Metabolic Syndrome: a Double-Blinded, Randomized Crossover Controlled Trial
This study investigates the effects of pomegranate juice on cardiovascular risk factors, revealing that while it lowers blood pressure and hs-CRP levels in patients with metabolic syndrome, it also increases triglyceride and VLDL-C levels.
DOI: 10.1007/s11130-017-0605-6 -
The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double‐blind clinical trial
In a randomized double-blind trial in adults with nonalcoholic fatty liver disease (NAFLD), daily pomegranate extract for 12 weeks improved anthropometric measures (weight, BMI, waist circumference), reduced triglycerides and total cholesterol, increased HDL-C, lowered fasting b…
DOI: 10.1002/ptr.7249 -
Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals consuming pomegranate: A randomized clinical trial
Pomegranate extract consumption improves cardiovascular risk biomarkers only in overweight-obese individuals with urolithin metabotype B, explaining interindividual variability.
DOI: 10.1002/mnfr.201600830 -
Effect of antioxidant capsule supplementation on oxidative stress markers in hypertensive patients
Four-week fruit-extract supplementation increased catalase activity in hypertensive and normotensive adults, but did not alter inflammatory cytokines, adipocytokines, SOD, FRAP, anthropometric, or haemodynamic measures.
DOI: 10.5937/scriptamed55-54200 -
Fresh pomegranate juice ameliorates insulin resistance, enhances β-cell function, and decreases fasting serum glucose in type 2 diabetic patients
This randomized clinical trial in Jordanian adults shows that a short-term intake of fresh pomegranate juice (1.5 mL/kg) decreased fasting serum glucose, increased β-cell function, and reduced insulin resistance 3 hours after consumption in type 2 diabetic patients, with no sign…
DOI: 10.1016/j.nutres.2014.08.003